Concepedia

Publication | Open Access

Secukinumab improves patient‐reported psoriasis symptoms of itching, pain, and scaling: results of two phase 3, randomized, placebo‐controlled clinical trials

40

Citations

8

References

2016

Year

Abstract

Secukinumab significantly improves patient-reported itching, pain, and scaling in adults with moderate to severe psoriasis compared with placebo.

References

YearCitations

Page 1